首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1548171

全球神經學栓塞裝置市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Embolization Devices For Neurology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年08月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球神經學栓塞設備市場需求預計將從 2023 年的 15.5 億美元達到近 21.4 億美元的市場規模，2024-2032 年研究期間複合年成長率為 3.62%。

神經病學栓塞裝置是一種專門的醫療器械，用於透過閉塞或阻塞大腦血管來治療神經系統疾病。這些設備用於血管內栓塞等手術中，以治療腦動脈瘤、動靜脈畸形和腫瘤等疾病。常見的栓塞裝置包括線圈、栓塞和液體栓塞劑，旨在誘導凝血並永久阻礙血液流向目標區域。透過減少或停止異常血管結構的血液供應，這些裝置有助於預防出血、降低壓力並治療各種神經系統疾病。使用栓塞裝置對於微創干預至關重要，它可以為患者提供有效的治療選擇，同時最大限度地減少手術風險和恢復時間。

市場動態

由於需要栓塞的神經系統疾病（例如腦動脈瘤和動靜脈畸形（AVM））的盛行率不斷增加，神經病學市場的栓塞設備正在經歷成長。隨著人口老化和診斷能力增強等因素的推動，這些疾病的發生率不斷上升，對有效栓塞治療的需求也不斷成長。技術進步正在創造巨大的市場機會。栓塞裝置材料和設計的創新，例如開發更俱生物相容性和靈活性的材料，正在提高治療的安全性和有效性。先進影像技術與栓塞設備的整合可實現更精確和受控的手術，從而改善患者的治療結果。

微創手術的成長趨勢也推動了神經學市場栓塞設備的成長。栓塞技術為傳統手術方法提供了侵入性較小的替代方案，從而縮短了恢復時間並降低了併發症的風險。這種向微創治療的轉變與人們越來越偏好最大限度地減少患者不適和縮短恢復時間的手術相一致。此外，新興市場擴大醫療基礎設施以及增加對神經病學和介入放射學的投資提供了巨大的成長機會。隨著這些地區醫療保健系統的進步，在專業治療的普及和對神經系統疾病的認知不斷提高的推動下，先進栓塞設備的採用預計將會增加。然而，高成本和手術風險可能會導致神經科栓塞裝置抑制市場成長。先進栓塞設備的巨額費用以及手術過程中可能出現的併發症可能會限制其廣泛採用，特別是在成本敏感或資源有限的醫療機構中。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球神經病學栓塞設備市場的各個細分市場進行了包容性評估。神經病學栓塞裝置產業的成長和趨勢為本研究提供了整體方法。

市場區隔

神經病學栓塞設備市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

栓塞線圈
液體栓塞系統
導流支架
動脈瘤夾
其他

按治療

缺血性中風解決方案
出血性中風解決方案

按指示

腦動脈瘤
動靜脈畸形（AVM）
其他

按最終用戶

醫院
門診手術中心
專科診所

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲神經病學栓塞設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。神經學栓塞設備市場的主要參與者包括 DePuy Synthes (Johnson & Johnson Services Inc.)、Terumo Medical Corporation、Stryker Corporation、Boston Scientific Corporation、Penumbra Inc.、Acandis GmbH、Balt Extrusion、Spartan Micro Inc.、B.布勞恩·梅爾松根股份公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 按處理方式進行的市場吸引力分析
- 按指標進行的市場吸引力分析
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球神經學栓塞設備市場分析：依產品

概述（按產品）
按產品分類的歷史和預測資料分析
栓塞線圈
液體栓塞系統
導流支架
動脈瘤夾
其他

第 6 章：全球神經學栓塞裝置市場分析：依治療分類

按治療概述
依處理方式進行歷史與預測資料分析
缺血性中風解決方案
出血性中風解決方案

第 7 章：全球神經學栓塞裝置市場分析：依適應症分類

按指示概述
按指示進行歷史和預測資料分析
腦動脈瘤
動靜脈畸形（AVM）
其他

第 8 章：全球神經學栓塞設備市場分析：依最終使用者分類

最終用戶概述
最終用戶的歷史和預測數據分析
醫院
門診手術中心
專科診所

第 9 章：全球神經學栓塞設備市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：神經科公司栓塞設備的競爭格局

神經病學市場競爭的栓塞裝置
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
DePuy Synthes (Johnson & Johnson Services Inc.)

公司概況
公司收入
產品
最新動態

Terumo Medical Corporation

公司概況
公司收入
產品
最新動態

Stryker Corporation

公司概況
公司收入
產品
最新動態

Boston Scientific Corporation

公司概況
公司收入
產品
最新動態

Penumbra Inc.

公司概況
公司收入
產品
最新動態

Acandis GmbH

公司概況
公司收入
產品
最新動態

Balt Extrusion

公司概況
公司收入
產品
最新動態

Spartan Micro Inc.

公司概況
公司收入
產品
最新動態

B. Braun Melsungen AG

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115500

The global demand for Embolization Devices For Neurology Market is presumed to reach the market size of nearly USD 2.14 Billion by 2032 from USD 1.55 Billion in 2023 with a CAGR of 3.62% under the study period 2024-2032.

Embolization devices for neurology are specialized medical instruments used to treat neurological conditions by occluding or blocking blood vessels in the brain. These devices are employed in procedures such as endovascular embolization to manage conditions like brain aneurysms, arteriovenous malformations, and tumors. Common embolization devices include coils, plugs, and liquid embolic agents, designed to induce clotting and permanently obstruct blood flow to targeted areas. By reducing or stopping the blood supply to abnormal vascular structures, these devices help to prevent bleeding, reduce pressure, and treat various neurological disorders. Using embolization devices is crucial for minimally invasive interventions, providing patients with effective treatment options while minimizing surgical risks and recovery times.

MARKET DYNAMICS

The embolization devices for neurology market is experiencing growth attributed to the increasing prevalence of neurological conditions requiring embolization, such as brain aneurysms and arteriovenous malformations (AVMs). As the incidence of these conditions rises, driven by factors such as aging populations & enhanced diagnostic capabilities, the demand for effective embolization treatments grows. Technological advancements are creating significant opportunities in the market. Innovations in embolization device materials and designs, such as the development of more biocompatible and flexible materials, are enhancing the safety and efficacy of treatments. The integration of advanced imaging technologies with embolization devices enables more precise and controlled procedures, improving patient outcomes.

The growing trend towards minimally invasive procedures also drives the growth of embolization devices for the neurology market. Embolization techniques offer less invasive alternatives to traditional surgical approaches, leading to shorter recovery times and reduced risk of complications. This shift towards less invasive treatments aligns with the increasing preference for procedures that minimize patient discomfort and recovery time. Additionally, expanding healthcare infrastructure and increasing investment in neurology and interventional radiology in emerging markets offer substantial growth opportunities. As healthcare systems in these areas progress, the adoption of advanced embolization devices is expected to rise, driven by improved access to specialized treatments and growing awareness of neurological conditions. However, high costs and procedural risks can cause embolization devices for neurology to restrain market growth. The significant expense of advanced embolization devices and the potential for complications during procedures may limit widespread adoption, particularly in cost-sensitive or resource-constrained healthcare settings.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Embolization Devices For Neurology. The growth and trends of Embolization Devices For Neurology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Embolization Devices For Neurology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Embolization Coils
Liquid Embolic Systems
Flow Diversion Stents
Aneurysm Clips
Others

By Treatment

Ischemic Stroke Solutions
Hemorrhagic Stroke Solutions

By Indication

Brain Aneurysms
Arteriovenous Malformation (AVM)
Others

By End User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Embolization Devices For Neurology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Embolization Devices For Neurology market include DePuy Synthes (Johnson & Johnson Services Inc.), Terumo Medical Corporation, Stryker Corporation, Boston Scientific Corporation, Penumbra Inc., Acandis GmbH, Balt Extrusion, Spartan Micro Inc., B. Braun Melsungen AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. EMBOLIZATION DEVICES FOR NEUROLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Treatment
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Embolization Coils Historic and Forecast Sales By Regions
5.4. Liquid Embolic Systems Historic and Forecast Sales By Regions
5.5. Flow Diversion Stents Historic and Forecast Sales By Regions
5.6. Aneurysm Clips Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY TREATMENT

6.1. Overview By Treatment
6.2. Historical and Forecast Data Analysis By Treatment
6.3. Ischemic Stroke Solutions Historic and Forecast Sales By Regions
6.4. Hemorrhagic Stroke Solutions Historic and Forecast Sales By Regions

7. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data Analysis By Indication
7.3. Brain Aneurysms Historic and Forecast Sales By Regions
7.4. Arteriovenous Malformation (AVM) Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY END USER

8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
8.5. Specialty Clinics Historic and Forecast Sales By Regions

9. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EMBOLIZATION DEVICES FOR NEUROLOGY COMPANIES

10.1. Embolization Devices For Neurology Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF EMBOLIZATION DEVICES FOR NEUROLOGY INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. DePuy Synthes (Johnson & Johnson Services Inc.)
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Terumo Medical Corporation
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Stryker Corporation
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Boston Scientific Corporation
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Penumbra Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Acandis GmbH
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Balt Extrusion
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Spartan Micro Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. B. Braun Melsungen AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments